KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Other financing activities (2016 - 2026)

AbbVie has reported Other financing activities over the past 14 years, most recently at $45.0 million for Q4 2025.

  • Quarterly Other financing activities rose 207.14% to $45.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $68.0 million through Dec 2025, up 19.3% year-over-year, with the annual reading at $68.0 million for FY2025, 19.3% up from the prior year.
  • Other financing activities was $45.0 million for Q4 2025 at AbbVie, up from $3.0 million in the prior quarter.
  • Over five years, Other financing activities peaked at $99.0 million in Q1 2024 and troughed at -$75.0 million in Q2 2024.
  • The 5-year median for Other financing activities is $10.0 million (2021), against an average of $12.6 million.
  • The largest YoY upside for Other financing activities was 625.0% in 2022 against a maximum downside of 650.0% in 2022.
  • A 5-year view of Other financing activities shows it stood at $2.0 million in 2021, then crashed by 650.0% to -$11.0 million in 2022, then surged by 536.36% to $48.0 million in 2023, then crashed by 187.5% to -$42.0 million in 2024, then skyrocketed by 207.14% to $45.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Other financing activities are $45.0 million (Q4 2025), $3.0 million (Q2 2025), and $20.0 million (Q1 2025).